Latest News and Press Releases
Want to stay updated on the latest news?
-
WEST LAFAYETTE, Ind., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of...
-
ANAHEIM, CA, Feb. 24, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use...
-
BOSTON, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic...
-
HERZLIYA, Israel, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Safe-T® Group Ltd. (Nasdaq, TASE: SFET), a provider of secure access solutions and intelligent data collection, announces today that Mr. Itay...
-
Leverkusen, Germany, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, announces the...
-
Platform system includes novel printer technology and advanced materials systemsPrinting speeds three times faster with greater precision than current standard industrial systemsHigh temperature...
-
CINCINNATI, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Workhorse Group Inc. (Nasdaq: WKHS) (“Workhorse” or the “Company”), an American technology company focused on providing sustainable and cost-effective...
-
NEW YORK and SEOUL, South Korea, Feb. 24, 2021 (GLOBE NEWSWIRE) -- SolarWindow Technologies, Inc. (Symbol: WNDW), today issued a stern warning to financial predators orchestrating a...
-
Intramyocardial injection of Lomecel-B well-tolerated, with no major cardiac events, and no serious adverse events related to Lomecel-B reported Full results of the Phase 1 clinical trial expected to...
-
Brooklyn, New York, Feb. 24, 2021 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the Nano-Dentistry Market will grow at a high CAGR value from...